nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—MTOR—epilepsy syndrome	0.258	0.708	CbGaD
Temsirolimus—CYP2D6—epilepsy syndrome	0.0622	0.17	CbGaD
Temsirolimus—ABCB1—epilepsy syndrome	0.0444	0.122	CbGaD
Temsirolimus—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0207	0.0518	CbGbCtD
Temsirolimus—CYP3A7—Carbamazepine—epilepsy syndrome	0.0173	0.0433	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0173	0.0433	CbGbCtD
Temsirolimus—CYP3A7—Phenytoin—epilepsy syndrome	0.0155	0.0389	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0155	0.0389	CbGbCtD
Temsirolimus—ABCB1—Levetiracetam—epilepsy syndrome	0.0147	0.0368	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0139	0.0346	CbGbCtD
Temsirolimus—CYP3A7—Phenobarbital—epilepsy syndrome	0.0139	0.0346	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0137	0.0342	CbGbCtD
Temsirolimus—CYP3A7—Midazolam—epilepsy syndrome	0.0137	0.0342	CbGbCtD
Temsirolimus—CYP3A7—Diazepam—epilepsy syndrome	0.0131	0.0328	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0131	0.0328	CbGbCtD
Temsirolimus—CYP3A5—Carbamazepine—epilepsy syndrome	0.013	0.0325	CbGbCtD
Temsirolimus—CYP3A5—Phenytoin—epilepsy syndrome	0.0117	0.0292	CbGbCtD
Temsirolimus—CYP3A5—Phenobarbital—epilepsy syndrome	0.0104	0.026	CbGbCtD
Temsirolimus—CYP3A5—Midazolam—epilepsy syndrome	0.0103	0.0256	CbGbCtD
Temsirolimus—ABCB1—Clobazam—epilepsy syndrome	0.0102	0.0255	CbGbCtD
Temsirolimus—CYP3A5—Diazepam—epilepsy syndrome	0.00986	0.0246	CbGbCtD
Temsirolimus—ABCB1—Lamotrigine—epilepsy syndrome	0.00983	0.0246	CbGbCtD
Temsirolimus—ABCB1—Carbamazepine—epilepsy syndrome	0.00846	0.0212	CbGbCtD
Temsirolimus—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00808	0.0202	CbGbCtD
Temsirolimus—CYP3A5—Valproic Acid—epilepsy syndrome	0.00777	0.0194	CbGbCtD
Temsirolimus—ABCB1—Phenytoin—epilepsy syndrome	0.00759	0.019	CbGbCtD
Temsirolimus—CYP3A4—Felbamate—epilepsy syndrome	0.00751	0.0188	CbGbCtD
Temsirolimus—CYP3A4—Trimethadione—epilepsy syndrome	0.00751	0.0188	CbGbCtD
Temsirolimus—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00706	0.0176	CbGbCtD
Temsirolimus—ABCB1—Phenobarbital—epilepsy syndrome	0.00677	0.0169	CbGbCtD
Temsirolimus—ABCB1—Midazolam—epilepsy syndrome	0.00667	0.0167	CbGbCtD
Temsirolimus—CYP2D6—Propofol—epilepsy syndrome	0.00667	0.0167	CbGbCtD
Temsirolimus—ABCB1—Diazepam—epilepsy syndrome	0.00641	0.016	CbGbCtD
Temsirolimus—CYP3A4—Clonazepam—epilepsy syndrome	0.00638	0.016	CbGbCtD
Temsirolimus—CYP3A4—Clobazam—epilepsy syndrome	0.00612	0.0153	CbGbCtD
Temsirolimus—CYP3A4—Rufinamide—epilepsy syndrome	0.0052	0.013	CbGbCtD
Temsirolimus—CYP3A4—Carbamazepine—epilepsy syndrome	0.00507	0.0127	CbGbCtD
Temsirolimus—CYP3A4—Primidone—epilepsy syndrome	0.00473	0.0118	CbGbCtD
Temsirolimus—CYP3A4—Phenytoin—epilepsy syndrome	0.00455	0.0114	CbGbCtD
Temsirolimus—CYP3A4—Propofol—epilepsy syndrome	0.00424	0.0106	CbGbCtD
Temsirolimus—CYP3A4—Phenobarbital—epilepsy syndrome	0.00405	0.0101	CbGbCtD
Temsirolimus—CYP3A4—Acetazolamide—epilepsy syndrome	0.00405	0.0101	CbGbCtD
Temsirolimus—CYP3A4—Midazolam—epilepsy syndrome	0.004	0.00999	CbGbCtD
Temsirolimus—CYP3A4—Diazepam—epilepsy syndrome	0.00384	0.00961	CbGbCtD
Temsirolimus—CYP3A4—Zonisamide—epilepsy syndrome	0.00375	0.00938	CbGbCtD
Temsirolimus—MTOR—forelimb—epilepsy syndrome	0.00351	0.2	CbGeAlD
Temsirolimus—CYP3A4—Valproic Acid—epilepsy syndrome	0.00303	0.00757	CbGbCtD
Temsirolimus—CYP3A4—Topiramate—epilepsy syndrome	0.00273	0.00683	CbGbCtD
Temsirolimus—MTOR—hindbrain—epilepsy syndrome	0.00144	0.0821	CbGeAlD
Temsirolimus—Everolimus—MTOR—epilepsy syndrome	0.000913	0.236	CrCbGaD
Temsirolimus—Pimecrolimus—MTOR—epilepsy syndrome	0.000913	0.236	CrCbGaD
Temsirolimus—MTOR—brainstem—epilepsy syndrome	0.000825	0.047	CbGeAlD
Temsirolimus—MTOR—forebrain—epilepsy syndrome	0.000796	0.0454	CbGeAlD
Temsirolimus—MTOR—telencephalon—epilepsy syndrome	0.000732	0.0418	CbGeAlD
Temsirolimus—FKBP1A—forebrain—epilepsy syndrome	0.000716	0.0408	CbGeAlD
Temsirolimus—Sirolimus—FGF2—epilepsy syndrome	0.000666	0.172	CrCbGaD
Temsirolimus—FKBP1A—telencephalon—epilepsy syndrome	0.000658	0.0376	CbGeAlD
Temsirolimus—Tacrolimus—MTOR—epilepsy syndrome	0.000543	0.141	CrCbGaD
Temsirolimus—Sirolimus—MTOR—epilepsy syndrome	0.000543	0.141	CrCbGaD
Temsirolimus—FKBP1A—medulla oblongata—epilepsy syndrome	0.000517	0.0295	CbGeAlD
Temsirolimus—MTOR—spinal cord—epilepsy syndrome	0.000513	0.0293	CbGeAlD
Temsirolimus—FKBP1A—midbrain—epilepsy syndrome	0.000473	0.027	CbGeAlD
Temsirolimus—FKBP1A—spinal cord—epilepsy syndrome	0.000461	0.0263	CbGeAlD
Temsirolimus—MTOR—head—epilepsy syndrome	0.000456	0.026	CbGeAlD
Temsirolimus—MTOR—nervous system—epilepsy syndrome	0.000432	0.0246	CbGeAlD
Temsirolimus—CYP2D6—hindbrain—epilepsy syndrome	0.000416	0.0237	CbGeAlD
Temsirolimus—MTOR—central nervous system—epilepsy syndrome	0.000416	0.0237	CbGeAlD
Temsirolimus—FKBP1A—head—epilepsy syndrome	0.00041	0.0234	CbGeAlD
Temsirolimus—MTOR—cerebellum—epilepsy syndrome	0.000407	0.0232	CbGeAlD
Temsirolimus—FKBP1A—nervous system—epilepsy syndrome	0.000389	0.0222	CbGeAlD
Temsirolimus—FKBP1A—central nervous system—epilepsy syndrome	0.000374	0.0213	CbGeAlD
Temsirolimus—FKBP1A—cerebellum—epilepsy syndrome	0.000366	0.0209	CbGeAlD
Temsirolimus—MTOR—brain—epilepsy syndrome	0.00033	0.0188	CbGeAlD
Temsirolimus—FKBP1A—brain—epilepsy syndrome	0.000297	0.0169	CbGeAlD
Temsirolimus—CYP2D6—brainstem—epilepsy syndrome	0.000239	0.0136	CbGeAlD
Temsirolimus—CYP2D6—forebrain—epilepsy syndrome	0.00023	0.0131	CbGeAlD
Temsirolimus—CYP2D6—telencephalon—epilepsy syndrome	0.000212	0.0121	CbGeAlD
Temsirolimus—ABCB1—forebrain—epilepsy syndrome	0.000166	0.00945	CbGeAlD
Temsirolimus—ABCB1—telencephalon—epilepsy syndrome	0.000152	0.00869	CbGeAlD
Temsirolimus—CYP2D6—head—epilepsy syndrome	0.000132	0.00752	CbGeAlD
Temsirolimus—CYP3A4—nervous system—epilepsy syndrome	0.000127	0.00725	CbGeAlD
Temsirolimus—CYP2D6—nervous system—epilepsy syndrome	0.000125	0.00713	CbGeAlD
Temsirolimus—CYP3A4—central nervous system—epilepsy syndrome	0.000122	0.00698	CbGeAlD
Temsirolimus—CYP2D6—central nervous system—epilepsy syndrome	0.00012	0.00686	CbGeAlD
Temsirolimus—ABCB1—medulla oblongata—epilepsy syndrome	0.00012	0.00683	CbGeAlD
Temsirolimus—CYP2D6—cerebellum—epilepsy syndrome	0.000118	0.00671	CbGeAlD
Temsirolimus—ABCB1—midbrain—epilepsy syndrome	0.000109	0.00624	CbGeAlD
Temsirolimus—ABCB1—spinal cord—epilepsy syndrome	0.000107	0.00609	CbGeAlD
Temsirolimus—Tacrolimus—ALB—epilepsy syndrome	9.78e-05	0.0253	CrCbGaD
Temsirolimus—CYP2D6—brain—epilepsy syndrome	9.56e-05	0.00545	CbGeAlD
Temsirolimus—ABCB1—head—epilepsy syndrome	9.48e-05	0.00541	CbGeAlD
Temsirolimus—Sirolimus—ABCB1—epilepsy syndrome	9.34e-05	0.0242	CrCbGaD
Temsirolimus—Tacrolimus—ABCB1—epilepsy syndrome	9.34e-05	0.0242	CrCbGaD
Temsirolimus—ABCB1—nervous system—epilepsy syndrome	8.99e-05	0.00513	CbGeAlD
Temsirolimus—ABCB1—central nervous system—epilepsy syndrome	8.66e-05	0.00494	CbGeAlD
Temsirolimus—ABCB1—cerebellum—epilepsy syndrome	8.46e-05	0.00483	CbGeAlD
Temsirolimus—ABCB1—brain—epilepsy syndrome	6.87e-05	0.00392	CbGeAlD
Temsirolimus—Pruritus—Zonisamide—epilepsy syndrome	4.49e-05	0.000297	CcSEcCtD
Temsirolimus—Hypersensitivity—Phenytoin—epilepsy syndrome	4.48e-05	0.000296	CcSEcCtD
Temsirolimus—Oedema—Valproic Acid—epilepsy syndrome	4.46e-05	0.000295	CcSEcCtD
Temsirolimus—Anaphylactic shock—Valproic Acid—epilepsy syndrome	4.46e-05	0.000295	CcSEcCtD
Temsirolimus—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	4.46e-05	0.000294	CcSEcCtD
Temsirolimus—Nausea—Propofol—epilepsy syndrome	4.45e-05	0.000294	CcSEcCtD
Temsirolimus—Vomiting—Fosphenytoin—epilepsy syndrome	4.44e-05	0.000294	CcSEcCtD
Temsirolimus—Diarrhoea—Felbamate—epilepsy syndrome	4.44e-05	0.000293	CcSEcCtD
Temsirolimus—Body temperature increased—Lamotrigine—epilepsy syndrome	4.43e-05	0.000293	CcSEcCtD
Temsirolimus—Abdominal pain—Lamotrigine—epilepsy syndrome	4.43e-05	0.000293	CcSEcCtD
Temsirolimus—Dysgeusia—Gabapentin—epilepsy syndrome	4.43e-05	0.000293	CcSEcCtD
Temsirolimus—Dizziness—Diazepam—epilepsy syndrome	4.43e-05	0.000293	CcSEcCtD
Temsirolimus—Infection—Valproic Acid—epilepsy syndrome	4.43e-05	0.000293	CcSEcCtD
Temsirolimus—Leukopenia—Pregabalin—epilepsy syndrome	4.42e-05	0.000292	CcSEcCtD
Temsirolimus—Rash—Fosphenytoin—epilepsy syndrome	4.4e-05	0.000291	CcSEcCtD
Temsirolimus—Dermatitis—Fosphenytoin—epilepsy syndrome	4.4e-05	0.000291	CcSEcCtD
Temsirolimus—Asthenia—Clonazepam—epilepsy syndrome	4.39e-05	0.00029	CcSEcCtD
Temsirolimus—Rhinitis—Topiramate—epilepsy syndrome	4.39e-05	0.00029	CcSEcCtD
Temsirolimus—Back pain—Gabapentin—epilepsy syndrome	4.38e-05	0.000289	CcSEcCtD
Temsirolimus—Headache—Fosphenytoin—epilepsy syndrome	4.38e-05	0.000289	CcSEcCtD
Temsirolimus—Nervous system disorder—Valproic Acid—epilepsy syndrome	4.37e-05	0.000289	CcSEcCtD
Temsirolimus—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.36e-05	0.000288	CcSEcCtD
Temsirolimus—Asthenia—Phenytoin—epilepsy syndrome	4.36e-05	0.000288	CcSEcCtD
Temsirolimus—Nausea—Midazolam—epilepsy syndrome	4.35e-05	0.000288	CcSEcCtD
Temsirolimus—Diarrhoea—Zonisamide—epilepsy syndrome	4.35e-05	0.000287	CcSEcCtD
Temsirolimus—Pharyngitis—Topiramate—epilepsy syndrome	4.34e-05	0.000287	CcSEcCtD
Temsirolimus—Asthenia—Oxcarbazepine—epilepsy syndrome	4.34e-05	0.000287	CcSEcCtD
Temsirolimus—Pruritus—Clonazepam—epilepsy syndrome	4.33e-05	0.000286	CcSEcCtD
Temsirolimus—Vomiting—Vigabatrin—epilepsy syndrome	4.33e-05	0.000286	CcSEcCtD
Temsirolimus—Skin disorder—Valproic Acid—epilepsy syndrome	4.33e-05	0.000286	CcSEcCtD
Temsirolimus—Urinary tract disorder—Topiramate—epilepsy syndrome	4.32e-05	0.000286	CcSEcCtD
Temsirolimus—Oedema peripheral—Topiramate—epilepsy syndrome	4.31e-05	0.000285	CcSEcCtD
Temsirolimus—Cough—Pregabalin—epilepsy syndrome	4.31e-05	0.000285	CcSEcCtD
Temsirolimus—Pruritus—Phenytoin—epilepsy syndrome	4.3e-05	0.000284	CcSEcCtD
Temsirolimus—Connective tissue disorder—Topiramate—epilepsy syndrome	4.3e-05	0.000284	CcSEcCtD
Temsirolimus—Nausea—Levetiracetam—epilepsy syndrome	4.3e-05	0.000284	CcSEcCtD
Temsirolimus—Rash—Vigabatrin—epilepsy syndrome	4.29e-05	0.000284	CcSEcCtD
Temsirolimus—Dizziness—Felbamate—epilepsy syndrome	4.29e-05	0.000284	CcSEcCtD
Temsirolimus—Dermatitis—Vigabatrin—epilepsy syndrome	4.29e-05	0.000283	CcSEcCtD
Temsirolimus—Urethral disorder—Topiramate—epilepsy syndrome	4.29e-05	0.000283	CcSEcCtD
Temsirolimus—Pruritus—Oxcarbazepine—epilepsy syndrome	4.28e-05	0.000283	CcSEcCtD
Temsirolimus—Convulsion—Pregabalin—epilepsy syndrome	4.28e-05	0.000283	CcSEcCtD
Temsirolimus—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.28e-05	0.000283	CcSEcCtD
Temsirolimus—Headache—Vigabatrin—epilepsy syndrome	4.27e-05	0.000282	CcSEcCtD
Temsirolimus—Hypertension—Pregabalin—epilepsy syndrome	4.26e-05	0.000282	CcSEcCtD
Temsirolimus—Vomiting—Diazepam—epilepsy syndrome	4.26e-05	0.000282	CcSEcCtD
Temsirolimus—Anorexia—Valproic Acid—epilepsy syndrome	4.25e-05	0.000281	CcSEcCtD
Temsirolimus—Rash—Diazepam—epilepsy syndrome	4.23e-05	0.000279	CcSEcCtD
Temsirolimus—Dermatitis—Diazepam—epilepsy syndrome	4.22e-05	0.000279	CcSEcCtD
Temsirolimus—Chest pain—Pregabalin—epilepsy syndrome	4.2e-05	0.000278	CcSEcCtD
Temsirolimus—Myalgia—Pregabalin—epilepsy syndrome	4.2e-05	0.000278	CcSEcCtD
Temsirolimus—Arthralgia—Pregabalin—epilepsy syndrome	4.2e-05	0.000278	CcSEcCtD
Temsirolimus—Dizziness—Zonisamide—epilepsy syndrome	4.2e-05	0.000278	CcSEcCtD
Temsirolimus—Headache—Diazepam—epilepsy syndrome	4.2e-05	0.000278	CcSEcCtD
Temsirolimus—Anxiety—Pregabalin—epilepsy syndrome	4.19e-05	0.000277	CcSEcCtD
Temsirolimus—Diarrhoea—Clonazepam—epilepsy syndrome	4.19e-05	0.000277	CcSEcCtD
Temsirolimus—Anaemia—Gabapentin—epilepsy syndrome	4.18e-05	0.000277	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.17e-05	0.000276	CcSEcCtD
Temsirolimus—Asthenia—Carbamazepine—epilepsy syndrome	4.16e-05	0.000275	CcSEcCtD
Temsirolimus—Diarrhoea—Phenytoin—epilepsy syndrome	4.16e-05	0.000275	CcSEcCtD
Temsirolimus—Nausea—Fosphenytoin—epilepsy syndrome	4.15e-05	0.000274	CcSEcCtD
Temsirolimus—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.14e-05	0.000273	CcSEcCtD
Temsirolimus—Erythema multiforme—Topiramate—epilepsy syndrome	4.14e-05	0.000273	CcSEcCtD
Temsirolimus—Angioedema—Gabapentin—epilepsy syndrome	4.14e-05	0.000273	CcSEcCtD
Temsirolimus—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.13e-05	0.000273	CcSEcCtD
Temsirolimus—Vomiting—Felbamate—epilepsy syndrome	4.13e-05	0.000273	CcSEcCtD
Temsirolimus—Pruritus—Carbamazepine—epilepsy syndrome	4.11e-05	0.000271	CcSEcCtD
Temsirolimus—Rash—Felbamate—epilepsy syndrome	4.09e-05	0.00027	CcSEcCtD
Temsirolimus—Eye disorder—Topiramate—epilepsy syndrome	4.09e-05	0.00027	CcSEcCtD
Temsirolimus—Dermatitis—Felbamate—epilepsy syndrome	4.09e-05	0.00027	CcSEcCtD
Temsirolimus—Headache—Felbamate—epilepsy syndrome	4.06e-05	0.000269	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.06e-05	0.000268	CcSEcCtD
Temsirolimus—Cardiac disorder—Topiramate—epilepsy syndrome	4.06e-05	0.000268	CcSEcCtD
Temsirolimus—Leukopenia—Gabapentin—epilepsy syndrome	4.05e-05	0.000268	CcSEcCtD
Temsirolimus—Dizziness—Clonazepam—epilepsy syndrome	4.05e-05	0.000267	CcSEcCtD
Temsirolimus—Nausea—Vigabatrin—epilepsy syndrome	4.04e-05	0.000267	CcSEcCtD
Temsirolimus—Vomiting—Zonisamide—epilepsy syndrome	4.04e-05	0.000267	CcSEcCtD
Temsirolimus—Insomnia—Valproic Acid—epilepsy syndrome	4.03e-05	0.000266	CcSEcCtD
Temsirolimus—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.03e-05	0.000266	CcSEcCtD
Temsirolimus—Oedema—Pregabalin—epilepsy syndrome	4.03e-05	0.000266	CcSEcCtD
Temsirolimus—Asthenia—Lamotrigine—epilepsy syndrome	4.02e-05	0.000266	CcSEcCtD
Temsirolimus—Dizziness—Phenytoin—epilepsy syndrome	4.02e-05	0.000266	CcSEcCtD
Temsirolimus—Rash—Zonisamide—epilepsy syndrome	4e-05	0.000265	CcSEcCtD
Temsirolimus—Infection—Pregabalin—epilepsy syndrome	4e-05	0.000265	CcSEcCtD
Temsirolimus—Dermatitis—Zonisamide—epilepsy syndrome	4e-05	0.000264	CcSEcCtD
Temsirolimus—Dizziness—Oxcarbazepine—epilepsy syndrome	4e-05	0.000264	CcSEcCtD
Temsirolimus—Nausea—Diazepam—epilepsy syndrome	3.98e-05	0.000263	CcSEcCtD
Temsirolimus—Headache—Zonisamide—epilepsy syndrome	3.98e-05	0.000263	CcSEcCtD
Temsirolimus—Dyspnoea—Valproic Acid—epilepsy syndrome	3.97e-05	0.000263	CcSEcCtD
Temsirolimus—Diarrhoea—Carbamazepine—epilepsy syndrome	3.97e-05	0.000262	CcSEcCtD
Temsirolimus—Angiopathy—Topiramate—epilepsy syndrome	3.97e-05	0.000262	CcSEcCtD
Temsirolimus—Pruritus—Lamotrigine—epilepsy syndrome	3.97e-05	0.000262	CcSEcCtD
Temsirolimus—Somnolence—Valproic Acid—epilepsy syndrome	3.96e-05	0.000262	CcSEcCtD
Temsirolimus—Immune system disorder—Topiramate—epilepsy syndrome	3.95e-05	0.000261	CcSEcCtD
Temsirolimus—Nervous system disorder—Pregabalin—epilepsy syndrome	3.95e-05	0.000261	CcSEcCtD
Temsirolimus—Cough—Gabapentin—epilepsy syndrome	3.95e-05	0.000261	CcSEcCtD
Temsirolimus—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.95e-05	0.000261	CcSEcCtD
Temsirolimus—Mediastinal disorder—Topiramate—epilepsy syndrome	3.94e-05	0.000261	CcSEcCtD
Temsirolimus—Chills—Topiramate—epilepsy syndrome	3.93e-05	0.000259	CcSEcCtD
Temsirolimus—Convulsion—Gabapentin—epilepsy syndrome	3.92e-05	0.000259	CcSEcCtD
Temsirolimus—Skin disorder—Pregabalin—epilepsy syndrome	3.91e-05	0.000259	CcSEcCtD
Temsirolimus—Hypertension—Gabapentin—epilepsy syndrome	3.91e-05	0.000258	CcSEcCtD
Temsirolimus—Vomiting—Clonazepam—epilepsy syndrome	3.89e-05	0.000257	CcSEcCtD
Temsirolimus—Decreased appetite—Valproic Acid—epilepsy syndrome	3.87e-05	0.000256	CcSEcCtD
Temsirolimus—Vomiting—Phenytoin—epilepsy syndrome	3.87e-05	0.000255	CcSEcCtD
Temsirolimus—Rash—Clonazepam—epilepsy syndrome	3.86e-05	0.000255	CcSEcCtD
Temsirolimus—Dermatitis—Clonazepam—epilepsy syndrome	3.86e-05	0.000255	CcSEcCtD
Temsirolimus—Chest pain—Gabapentin—epilepsy syndrome	3.85e-05	0.000255	CcSEcCtD
Temsirolimus—Myalgia—Gabapentin—epilepsy syndrome	3.85e-05	0.000255	CcSEcCtD
Temsirolimus—Arthralgia—Gabapentin—epilepsy syndrome	3.85e-05	0.000255	CcSEcCtD
Temsirolimus—Nausea—Felbamate—epilepsy syndrome	3.85e-05	0.000255	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.85e-05	0.000254	CcSEcCtD
Temsirolimus—Vomiting—Oxcarbazepine—epilepsy syndrome	3.85e-05	0.000254	CcSEcCtD
Temsirolimus—Fatigue—Valproic Acid—epilepsy syndrome	3.84e-05	0.000254	CcSEcCtD
Temsirolimus—Anxiety—Gabapentin—epilepsy syndrome	3.84e-05	0.000254	CcSEcCtD
Temsirolimus—Anorexia—Pregabalin—epilepsy syndrome	3.84e-05	0.000254	CcSEcCtD
Temsirolimus—Dizziness—Carbamazepine—epilepsy syndrome	3.84e-05	0.000254	CcSEcCtD
Temsirolimus—Diarrhoea—Lamotrigine—epilepsy syndrome	3.84e-05	0.000254	CcSEcCtD
Temsirolimus—Headache—Clonazepam—epilepsy syndrome	3.83e-05	0.000253	CcSEcCtD
Temsirolimus—Rash—Phenytoin—epilepsy syndrome	3.83e-05	0.000253	CcSEcCtD
Temsirolimus—Mental disorder—Topiramate—epilepsy syndrome	3.83e-05	0.000253	CcSEcCtD
Temsirolimus—Dermatitis—Phenytoin—epilepsy syndrome	3.83e-05	0.000253	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.83e-05	0.000253	CcSEcCtD
Temsirolimus—Rash—Oxcarbazepine—epilepsy syndrome	3.81e-05	0.000252	CcSEcCtD
Temsirolimus—Constipation—Valproic Acid—epilepsy syndrome	3.81e-05	0.000252	CcSEcCtD
Temsirolimus—Pain—Valproic Acid—epilepsy syndrome	3.81e-05	0.000252	CcSEcCtD
Temsirolimus—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.81e-05	0.000252	CcSEcCtD
Temsirolimus—Headache—Phenytoin—epilepsy syndrome	3.81e-05	0.000252	CcSEcCtD
Temsirolimus—Erythema—Topiramate—epilepsy syndrome	3.81e-05	0.000252	CcSEcCtD
Temsirolimus—Malnutrition—Topiramate—epilepsy syndrome	3.81e-05	0.000252	CcSEcCtD
Temsirolimus—Headache—Oxcarbazepine—epilepsy syndrome	3.79e-05	0.00025	CcSEcCtD
Temsirolimus—Nausea—Zonisamide—epilepsy syndrome	3.77e-05	0.000249	CcSEcCtD
Temsirolimus—Dysgeusia—Topiramate—epilepsy syndrome	3.73e-05	0.000246	CcSEcCtD
Temsirolimus—Dizziness—Lamotrigine—epilepsy syndrome	3.71e-05	0.000245	CcSEcCtD
Temsirolimus—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.7e-05	0.000244	CcSEcCtD
Temsirolimus—Oedema—Gabapentin—epilepsy syndrome	3.7e-05	0.000244	CcSEcCtD
Temsirolimus—Vomiting—Carbamazepine—epilepsy syndrome	3.69e-05	0.000244	CcSEcCtD
Temsirolimus—Back pain—Topiramate—epilepsy syndrome	3.68e-05	0.000243	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.67e-05	0.000243	CcSEcCtD
Temsirolimus—Infection—Gabapentin—epilepsy syndrome	3.67e-05	0.000243	CcSEcCtD
Temsirolimus—Rash—Carbamazepine—epilepsy syndrome	3.66e-05	0.000242	CcSEcCtD
Temsirolimus—Dermatitis—Carbamazepine—epilepsy syndrome	3.66e-05	0.000242	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.64e-05	0.000241	CcSEcCtD
Temsirolimus—Insomnia—Pregabalin—epilepsy syndrome	3.64e-05	0.000241	CcSEcCtD
Temsirolimus—Nausea—Clonazepam—epilepsy syndrome	3.64e-05	0.00024	CcSEcCtD
Temsirolimus—Headache—Carbamazepine—epilepsy syndrome	3.64e-05	0.00024	CcSEcCtD
Temsirolimus—Nervous system disorder—Gabapentin—epilepsy syndrome	3.62e-05	0.000239	CcSEcCtD
Temsirolimus—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.62e-05	0.000239	CcSEcCtD
Temsirolimus—Nausea—Phenytoin—epilepsy syndrome	3.61e-05	0.000239	CcSEcCtD
Temsirolimus—Dyspnoea—Pregabalin—epilepsy syndrome	3.59e-05	0.000237	CcSEcCtD
Temsirolimus—Nausea—Oxcarbazepine—epilepsy syndrome	3.59e-05	0.000237	CcSEcCtD
Temsirolimus—Skin disorder—Gabapentin—epilepsy syndrome	3.59e-05	0.000237	CcSEcCtD
Temsirolimus—Somnolence—Pregabalin—epilepsy syndrome	3.58e-05	0.000237	CcSEcCtD
Temsirolimus—Vomiting—Lamotrigine—epilepsy syndrome	3.57e-05	0.000236	CcSEcCtD
Temsirolimus—Rash—Lamotrigine—epilepsy syndrome	3.54e-05	0.000234	CcSEcCtD
Temsirolimus—Dermatitis—Lamotrigine—epilepsy syndrome	3.53e-05	0.000233	CcSEcCtD
Temsirolimus—Abdominal pain—Valproic Acid—epilepsy syndrome	3.52e-05	0.000233	CcSEcCtD
Temsirolimus—Body temperature increased—Valproic Acid—epilepsy syndrome	3.52e-05	0.000233	CcSEcCtD
Temsirolimus—Anorexia—Gabapentin—epilepsy syndrome	3.52e-05	0.000233	CcSEcCtD
Temsirolimus—Anaemia—Topiramate—epilepsy syndrome	3.52e-05	0.000233	CcSEcCtD
Temsirolimus—Headache—Lamotrigine—epilepsy syndrome	3.51e-05	0.000232	CcSEcCtD
Temsirolimus—Decreased appetite—Pregabalin—epilepsy syndrome	3.5e-05	0.000231	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.48e-05	0.00023	CcSEcCtD
Temsirolimus—Fatigue—Pregabalin—epilepsy syndrome	3.47e-05	0.00023	CcSEcCtD
Temsirolimus—Nausea—Carbamazepine—epilepsy syndrome	3.45e-05	0.000228	CcSEcCtD
Temsirolimus—Pain—Pregabalin—epilepsy syndrome	3.45e-05	0.000228	CcSEcCtD
Temsirolimus—Constipation—Pregabalin—epilepsy syndrome	3.45e-05	0.000228	CcSEcCtD
Temsirolimus—Leukopenia—Topiramate—epilepsy syndrome	3.41e-05	0.000225	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.37e-05	0.000222	CcSEcCtD
Temsirolimus—Insomnia—Gabapentin—epilepsy syndrome	3.34e-05	0.000221	CcSEcCtD
Temsirolimus—Nausea—Lamotrigine—epilepsy syndrome	3.33e-05	0.00022	CcSEcCtD
Temsirolimus—Cough—Topiramate—epilepsy syndrome	3.32e-05	0.00022	CcSEcCtD
Temsirolimus—Convulsion—Topiramate—epilepsy syndrome	3.3e-05	0.000218	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.3e-05	0.000218	CcSEcCtD
Temsirolimus—Dyspnoea—Gabapentin—epilepsy syndrome	3.29e-05	0.000218	CcSEcCtD
Temsirolimus—Hypertension—Topiramate—epilepsy syndrome	3.29e-05	0.000217	CcSEcCtD
Temsirolimus—Somnolence—Gabapentin—epilepsy syndrome	3.28e-05	0.000217	CcSEcCtD
Temsirolimus—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.28e-05	0.000217	CcSEcCtD
Temsirolimus—Myalgia—Topiramate—epilepsy syndrome	3.24e-05	0.000214	CcSEcCtD
Temsirolimus—Chest pain—Topiramate—epilepsy syndrome	3.24e-05	0.000214	CcSEcCtD
Temsirolimus—Arthralgia—Topiramate—epilepsy syndrome	3.24e-05	0.000214	CcSEcCtD
Temsirolimus—Anxiety—Topiramate—epilepsy syndrome	3.23e-05	0.000214	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.22e-05	0.000213	CcSEcCtD
Temsirolimus—Decreased appetite—Gabapentin—epilepsy syndrome	3.21e-05	0.000212	CcSEcCtD
Temsirolimus—Asthenia—Valproic Acid—epilepsy syndrome	3.2e-05	0.000211	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.19e-05	0.000211	CcSEcCtD
Temsirolimus—Fatigue—Gabapentin—epilepsy syndrome	3.19e-05	0.000211	CcSEcCtD
Temsirolimus—Abdominal pain—Pregabalin—epilepsy syndrome	3.19e-05	0.00021	CcSEcCtD
Temsirolimus—Body temperature increased—Pregabalin—epilepsy syndrome	3.19e-05	0.00021	CcSEcCtD
Temsirolimus—Pain—Gabapentin—epilepsy syndrome	3.16e-05	0.000209	CcSEcCtD
Temsirolimus—Constipation—Gabapentin—epilepsy syndrome	3.16e-05	0.000209	CcSEcCtD
Temsirolimus—Pruritus—Valproic Acid—epilepsy syndrome	3.15e-05	0.000208	CcSEcCtD
Temsirolimus—Oedema—Topiramate—epilepsy syndrome	3.11e-05	0.000205	CcSEcCtD
Temsirolimus—Infection—Topiramate—epilepsy syndrome	3.09e-05	0.000204	CcSEcCtD
Temsirolimus—Diarrhoea—Valproic Acid—epilepsy syndrome	3.05e-05	0.000202	CcSEcCtD
Temsirolimus—Nervous system disorder—Topiramate—epilepsy syndrome	3.05e-05	0.000201	CcSEcCtD
Temsirolimus—Thrombocytopenia—Topiramate—epilepsy syndrome	3.04e-05	0.000201	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.02e-05	0.0002	CcSEcCtD
Temsirolimus—Skin disorder—Topiramate—epilepsy syndrome	3.02e-05	0.0002	CcSEcCtD
Temsirolimus—Hypersensitivity—Pregabalin—epilepsy syndrome	2.97e-05	0.000196	CcSEcCtD
Temsirolimus—Anorexia—Topiramate—epilepsy syndrome	2.96e-05	0.000196	CcSEcCtD
Temsirolimus—Dizziness—Valproic Acid—epilepsy syndrome	2.95e-05	0.000195	CcSEcCtD
Temsirolimus—Body temperature increased—Gabapentin—epilepsy syndrome	2.92e-05	0.000193	CcSEcCtD
Temsirolimus—Abdominal pain—Gabapentin—epilepsy syndrome	2.92e-05	0.000193	CcSEcCtD
Temsirolimus—Asthenia—Pregabalin—epilepsy syndrome	2.89e-05	0.000191	CcSEcCtD
Temsirolimus—Pruritus—Pregabalin—epilepsy syndrome	2.85e-05	0.000188	CcSEcCtD
Temsirolimus—Vomiting—Valproic Acid—epilepsy syndrome	2.83e-05	0.000187	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.83e-05	0.000187	CcSEcCtD
Temsirolimus—Insomnia—Topiramate—epilepsy syndrome	2.81e-05	0.000186	CcSEcCtD
Temsirolimus—Rash—Valproic Acid—epilepsy syndrome	2.81e-05	0.000186	CcSEcCtD
Temsirolimus—Dermatitis—Valproic Acid—epilepsy syndrome	2.81e-05	0.000186	CcSEcCtD
Temsirolimus—Headache—Valproic Acid—epilepsy syndrome	2.79e-05	0.000185	CcSEcCtD
Temsirolimus—Dyspnoea—Topiramate—epilepsy syndrome	2.77e-05	0.000183	CcSEcCtD
Temsirolimus—Somnolence—Topiramate—epilepsy syndrome	2.76e-05	0.000183	CcSEcCtD
Temsirolimus—Diarrhoea—Pregabalin—epilepsy syndrome	2.76e-05	0.000182	CcSEcCtD
Temsirolimus—Hypersensitivity—Gabapentin—epilepsy syndrome	2.72e-05	0.00018	CcSEcCtD
Temsirolimus—Decreased appetite—Topiramate—epilepsy syndrome	2.7e-05	0.000179	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.68e-05	0.000177	CcSEcCtD
Temsirolimus—Fatigue—Topiramate—epilepsy syndrome	2.68e-05	0.000177	CcSEcCtD
Temsirolimus—Dizziness—Pregabalin—epilepsy syndrome	2.66e-05	0.000176	CcSEcCtD
Temsirolimus—Pain—Topiramate—epilepsy syndrome	2.66e-05	0.000176	CcSEcCtD
Temsirolimus—Constipation—Topiramate—epilepsy syndrome	2.66e-05	0.000176	CcSEcCtD
Temsirolimus—Asthenia—Gabapentin—epilepsy syndrome	2.65e-05	0.000175	CcSEcCtD
Temsirolimus—Nausea—Valproic Acid—epilepsy syndrome	2.65e-05	0.000175	CcSEcCtD
Temsirolimus—Pruritus—Gabapentin—epilepsy syndrome	2.61e-05	0.000173	CcSEcCtD
Temsirolimus—Vomiting—Pregabalin—epilepsy syndrome	2.56e-05	0.000169	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.54e-05	0.000168	CcSEcCtD
Temsirolimus—Rash—Pregabalin—epilepsy syndrome	2.54e-05	0.000168	CcSEcCtD
Temsirolimus—Dermatitis—Pregabalin—epilepsy syndrome	2.54e-05	0.000168	CcSEcCtD
Temsirolimus—Diarrhoea—Gabapentin—epilepsy syndrome	2.53e-05	0.000167	CcSEcCtD
Temsirolimus—Headache—Pregabalin—epilepsy syndrome	2.52e-05	0.000167	CcSEcCtD
Temsirolimus—Abdominal pain—Topiramate—epilepsy syndrome	2.46e-05	0.000162	CcSEcCtD
Temsirolimus—Body temperature increased—Topiramate—epilepsy syndrome	2.46e-05	0.000162	CcSEcCtD
Temsirolimus—Dizziness—Gabapentin—epilepsy syndrome	2.44e-05	0.000161	CcSEcCtD
Temsirolimus—Nausea—Pregabalin—epilepsy syndrome	2.39e-05	0.000158	CcSEcCtD
Temsirolimus—Vomiting—Gabapentin—epilepsy syndrome	2.35e-05	0.000155	CcSEcCtD
Temsirolimus—Rash—Gabapentin—epilepsy syndrome	2.33e-05	0.000154	CcSEcCtD
Temsirolimus—Dermatitis—Gabapentin—epilepsy syndrome	2.33e-05	0.000154	CcSEcCtD
Temsirolimus—Headache—Gabapentin—epilepsy syndrome	2.31e-05	0.000153	CcSEcCtD
Temsirolimus—Hypersensitivity—Topiramate—epilepsy syndrome	2.29e-05	0.000151	CcSEcCtD
Temsirolimus—Asthenia—Topiramate—epilepsy syndrome	2.23e-05	0.000147	CcSEcCtD
Temsirolimus—Pruritus—Topiramate—epilepsy syndrome	2.2e-05	0.000145	CcSEcCtD
Temsirolimus—Nausea—Gabapentin—epilepsy syndrome	2.19e-05	0.000145	CcSEcCtD
Temsirolimus—Diarrhoea—Topiramate—epilepsy syndrome	2.13e-05	0.000141	CcSEcCtD
Temsirolimus—Dizziness—Topiramate—epilepsy syndrome	2.06e-05	0.000136	CcSEcCtD
Temsirolimus—Vomiting—Topiramate—epilepsy syndrome	1.98e-05	0.000131	CcSEcCtD
Temsirolimus—Rash—Topiramate—epilepsy syndrome	1.96e-05	0.00013	CcSEcCtD
Temsirolimus—Dermatitis—Topiramate—epilepsy syndrome	1.96e-05	0.000129	CcSEcCtD
Temsirolimus—Headache—Topiramate—epilepsy syndrome	1.95e-05	0.000129	CcSEcCtD
Temsirolimus—Nausea—Topiramate—epilepsy syndrome	1.85e-05	0.000122	CcSEcCtD
Temsirolimus—MTOR—Disease—HES1—epilepsy syndrome	7.39e-06	0.000119	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.38e-06	0.000119	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	7.37e-06	0.000119	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KDR—epilepsy syndrome	7.37e-06	0.000119	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTGS2—epilepsy syndrome	7.36e-06	0.000119	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.28e-06	0.000117	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.28e-06	0.000117	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.28e-06	0.000117	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.28e-06	0.000117	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	7.24e-06	0.000117	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SST—epilepsy syndrome	7.22e-06	0.000117	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR2—epilepsy syndrome	7.22e-06	0.000117	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NTRK2—epilepsy syndrome	7.22e-06	0.000117	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FYN—epilepsy syndrome	7.18e-06	0.000116	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	7.17e-06	0.000116	CbGpPWpGaD
Temsirolimus—MTOR—Disease—H2AFX—epilepsy syndrome	7.16e-06	0.000116	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DUSP6—epilepsy syndrome	7.15e-06	0.000116	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	7.1e-06	0.000115	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	7.1e-06	0.000115	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PRKCB—epilepsy syndrome	7.1e-06	0.000115	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	7.07e-06	0.000114	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	7.07e-06	0.000114	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6ST—epilepsy syndrome	7.07e-06	0.000114	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADRA2A—epilepsy syndrome	7.06e-06	0.000114	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PLAT—epilepsy syndrome	7.03e-06	0.000114	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	7e-06	0.000113	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NT5E—epilepsy syndrome	6.99e-06	0.000113	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALAD—epilepsy syndrome	6.99e-06	0.000113	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—JUN—epilepsy syndrome	6.94e-06	0.000112	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	6.92e-06	0.000112	CbGpPWpGaD
Temsirolimus—MTOR—Disease—YWHAZ—epilepsy syndrome	6.9e-06	0.000111	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—BDKRB2—epilepsy syndrome	6.79e-06	0.00011	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL12—epilepsy syndrome	6.79e-06	0.00011	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—AKT1—epilepsy syndrome	6.78e-06	0.00011	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ADSL—epilepsy syndrome	6.78e-06	0.00011	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.76e-06	0.000109	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—QDPR—epilepsy syndrome	6.76e-06	0.000109	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.74e-06	0.000109	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TSC2—epilepsy syndrome	6.69e-06	0.000108	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CRP—epilepsy syndrome	6.69e-06	0.000108	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	6.67e-06	0.000108	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	6.67e-06	0.000108	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	6.67e-06	0.000108	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—JUNB—epilepsy syndrome	6.66e-06	0.000108	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CNR1—epilepsy syndrome	6.66e-06	0.000108	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GLUL—epilepsy syndrome	6.65e-06	0.000107	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CCR5—epilepsy syndrome	6.64e-06	0.000107	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—BCHE—epilepsy syndrome	6.64e-06	0.000107	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PLCB1—epilepsy syndrome	6.64e-06	0.000107	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	6.53e-06	0.000105	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	6.52e-06	0.000105	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR7—epilepsy syndrome	6.5e-06	0.000105	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	6.49e-06	0.000105	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—POMC—epilepsy syndrome	6.46e-06	0.000104	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.39e-06	0.000103	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.36e-06	0.000103	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	6.33e-06	0.000102	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL2—epilepsy syndrome	6.32e-06	0.000102	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.32e-06	0.000102	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HBEGF—epilepsy syndrome	6.31e-06	0.000102	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.27e-06	0.000101	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	6.26e-06	0.000101	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—TH—epilepsy syndrome	6.24e-06	0.000101	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—SRC—epilepsy syndrome	6.23e-06	0.000101	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT3—epilepsy syndrome	6.19e-06	0.0001	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TSC2—epilepsy syndrome	6.17e-06	9.97e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PRKCB—epilepsy syndrome	6.17e-06	9.97e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.15e-06	9.93e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6ST—epilepsy syndrome	6.15e-06	9.93e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	6.11e-06	9.86e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.07e-06	9.8e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADAM10—epilepsy syndrome	6.05e-06	9.77e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOE—epilepsy syndrome	6.04e-06	9.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.03e-06	9.73e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.03e-06	9.73e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.03e-06	9.73e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.03e-06	9.73e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.03e-06	9.73e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.01e-06	9.71e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—SRC—epilepsy syndrome	5.98e-06	9.66e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SRC—epilepsy syndrome	5.95e-06	9.61e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AQP1—epilepsy syndrome	5.93e-06	9.57e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	5.79e-06	9.35e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.75e-06	9.29e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—S100B—epilepsy syndrome	5.72e-06	9.24e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGF2—epilepsy syndrome	5.72e-06	9.23e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6ST—epilepsy syndrome	5.68e-06	9.16e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SOCS3—epilepsy syndrome	5.66e-06	9.15e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDC42—epilepsy syndrome	5.65e-06	9.12e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	5.64e-06	9.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FOS—epilepsy syndrome	5.63e-06	9.09e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS2—epilepsy syndrome	5.63e-06	9.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	5.61e-06	9.06e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.59e-06	9.02e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.51e-06	8.9e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.51e-06	8.9e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.51e-06	8.9e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CASP8—epilepsy syndrome	5.5e-06	8.88e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AVP—epilepsy syndrome	5.47e-06	8.83e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.42e-06	8.75e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CHRM3—epilepsy syndrome	5.36e-06	8.66e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	5.36e-06	8.66e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.31e-06	8.57e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RELA—epilepsy syndrome	5.31e-06	8.57e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	5.21e-06	8.41e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MTOR—epilepsy syndrome	5.2e-06	8.4e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HES1—epilepsy syndrome	5.17e-06	8.35e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CAT—epilepsy syndrome	5.14e-06	8.3e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.13e-06	8.28e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.13e-06	8.28e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	5.06e-06	8.17e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.05e-06	8.16e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.05e-06	8.16e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FYN—epilepsy syndrome	5.03e-06	8.12e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—H2AFX—epilepsy syndrome	5.01e-06	8.09e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MEF2C—epilepsy syndrome	5e-06	8.08e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	5e-06	8.07e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FGF2—epilepsy syndrome	4.97e-06	8.03e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—YWHAZ—epilepsy syndrome	4.84e-06	7.81e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.82e-06	7.78e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	4.82e-06	7.78e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—BCHE—epilepsy syndrome	4.8e-06	7.75e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CASP3—epilepsy syndrome	4.79e-06	7.73e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NGF—epilepsy syndrome	4.78e-06	7.72e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—BCL2—epilepsy syndrome	4.72e-06	7.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.69e-06	7.57e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR5—epilepsy syndrome	4.65e-06	7.51e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GPX1—epilepsy syndrome	4.65e-06	7.51e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—JUN—epilepsy syndrome	4.65e-06	7.51e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—RELA—epilepsy syndrome	4.62e-06	7.45e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGF2—epilepsy syndrome	4.59e-06	7.41e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	4.58e-06	7.39e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.57e-06	7.38e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.57e-06	7.38e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR2A—epilepsy syndrome	4.55e-06	7.35e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	4.53e-06	7.31e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—epilepsy syndrome	4.52e-06	7.3e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TH—epilepsy syndrome	4.51e-06	7.29e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.37e-06	7.06e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.36e-06	7.04e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.36e-06	7.04e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TSC2—epilepsy syndrome	4.32e-06	6.98e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AGT—epilepsy syndrome	4.32e-06	6.97e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.27e-06	6.89e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.26e-06	6.88e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.23e-06	6.83e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOE—epilepsy syndrome	4.23e-06	6.83e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.18e-06	6.75e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—epilepsy syndrome	4.17e-06	6.74e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SRC—epilepsy syndrome	4.17e-06	6.73e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KDR—epilepsy syndrome	4.15e-06	6.69e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—epilepsy syndrome	4.14e-06	6.69e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.12e-06	6.65e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.1e-06	6.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AGT—epilepsy syndrome	4.08e-06	6.58e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—epilepsy syndrome	4.06e-06	6.56e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—JUN—epilepsy syndrome	4.04e-06	6.53e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.03e-06	6.51e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.02e-06	6.49e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.01e-06	6.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOE—epilepsy syndrome	3.99e-06	6.45e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PRKCB—epilepsy syndrome	3.99e-06	6.44e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.99e-06	6.44e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6ST—epilepsy syndrome	3.97e-06	6.42e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—AKT1—epilepsy syndrome	3.87e-06	6.25e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.82e-06	6.17e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	3.77e-06	6.08e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.76e-06	6.07e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—AKT1—epilepsy syndrome	3.72e-06	6e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CAT—epilepsy syndrome	3.72e-06	6e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—AKT1—epilepsy syndrome	3.7e-06	5.97e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.65e-06	5.9e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.64e-06	5.88e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.64e-06	5.87e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—POMC—epilepsy syndrome	3.63e-06	5.87e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—SRC—epilepsy syndrome	3.63e-06	5.86e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.62e-06	5.85e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	3.61e-06	5.84e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL2—epilepsy syndrome	3.56e-06	5.74e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.45e-06	5.58e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—POMC—epilepsy syndrome	3.43e-06	5.54e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.43e-06	5.53e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.42e-06	5.52e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.41e-06	5.51e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TH—epilepsy syndrome	3.4e-06	5.5e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GPX1—epilepsy syndrome	3.36e-06	5.43e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SRC—epilepsy syndrome	3.35e-06	5.41e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.3e-06	5.33e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.3e-06	5.33e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.26e-06	5.26e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.22e-06	5.2e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGF2—epilepsy syndrome	3.21e-06	5.19e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TH—epilepsy syndrome	3.21e-06	5.18e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—epilepsy syndrome	3.13e-06	5.05e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RELA—epilepsy syndrome	2.98e-06	4.82e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.95e-06	4.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.89e-06	4.66e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.84e-06	4.59e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CAT—epilepsy syndrome	2.8e-06	4.53e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	2.74e-06	4.42e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.69e-06	4.35e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CASP3—epilepsy syndrome	2.69e-06	4.35e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.68e-06	4.32e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.64e-06	4.27e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.62e-06	4.24e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—JUN—epilepsy syndrome	2.61e-06	4.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.61e-06	4.21e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AKT1—epilepsy syndrome	2.59e-06	4.18e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.57e-06	4.15e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—epilepsy syndrome	2.54e-06	4.11e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.54e-06	4.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—POMC—epilepsy syndrome	2.48e-06	4e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.39e-06	3.86e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.35e-06	3.8e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SRC—epilepsy syndrome	2.34e-06	3.79e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—epilepsy syndrome	2.28e-06	3.69e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—epilepsy syndrome	2.26e-06	3.65e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AKT1—epilepsy syndrome	2.25e-06	3.64e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.24e-06	3.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.23e-06	3.6e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AGT—epilepsy syndrome	2.22e-06	3.59e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOE—epilepsy syndrome	2.18e-06	3.52e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.13e-06	3.44e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.11e-06	3.4e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TH—epilepsy syndrome	2.1e-06	3.39e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.1e-06	3.38e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—AKT1—epilepsy syndrome	2.08e-06	3.36e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.05e-06	3.31e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.98e-06	3.19e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—POMC—epilepsy syndrome	1.87e-06	3.02e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.76e-06	2.85e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.75e-06	2.83e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.73e-06	2.79e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—epilepsy syndrome	1.71e-06	2.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.68e-06	2.71e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.61e-06	2.6e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.56e-06	2.52e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.49e-06	2.41e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT1—epilepsy syndrome	1.46e-06	2.35e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.41e-06	2.27e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.38e-06	2.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.37e-06	2.21e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.34e-06	2.17e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.15e-06	1.86e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.05e-06	1.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AKT1—epilepsy syndrome	9.94e-07	1.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.2e-07	1.49e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AKT1—epilepsy syndrome	7.5e-07	1.21e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.07e-07	1.14e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.62e-07	7.46e-06	CbGpPWpGaD
